Natera Corp - NTRA Net earnings per share for the last four quarters

Natera Inc (NTRA) - corporate logo

Effective management at Natera, Inc. (NTRA) has ensured the transition to a profitable genomic model. The history of percentage changes in EPS YoY (ttm) demonstrates profit dynamics, where the value of 50.20 characterizes this level. Proprietary cancer diagnostics allow the company to exercise pricing power regarding insurance payouts. The process concludes with the rapid delivery of biomaterials to laboratories via optimized courier routes.

Natera Inc (NTRA): Earnings per share for the last twelve months from 02/11/2024 to 11/17/2026

Natera Medical - analytical breakdowns and key metrics (NTRA)

- stock price and consensus target price:
Fundamental valuation:Natera (NTRA)
Finished products of Natera Corp

Natera, Inc. (NTRA) is actively scaling its staff of geneticists and bioinformaticians to expand its leadership in diagnostics. Hiring dynamics and operating expenses directly impact net income, which this indicator digitizes. The metric measures the rolling annual growth rate of earnings per share, revealing the business's ability to offset inflation. Analyzing the annual change in EPS (TTM) helps avoid overpaying for the asset when buying at local peaks.